Graham Dixon, PhD
Graham Dixon has a twenty year track record in research and development in pharmaceutical industry, particularly oncology, having held senior management positions within big pharma and biotech. Graham Dixon is currently Chief Scientific Officer/Head R&D for Onxeo, a publically listed biotech specialized in orphan oncology indications. For nearly ten years, Graham worked as Director of R&D with the European biotech Galapagos, accompanying its growth and international development. Graham Dixon holds a PhD in Biochemistry from the University of Swansea, Wales and an honors degree in Biology from the University of Bradford. He has numerous patents and scientific publications.